- DocumentoResumecaricato daAura Rachmawati
- DocumentoClinical Pathway IPDcaricato daAura Rachmawati
- DocumentoPANDUAN IMPLEMENTASI KODE EMERGENSI.docxcaricato daAura Rachmawati
- DocumentoDM TPE 2 USIA LANJUT.pdfcaricato daAura Rachmawati
- Documento297570846-FORMULIR-DPJP.docxcaricato daAura Rachmawati
- Documento377977395 Panduan Code Redcaricato daAura Rachmawati
- DocumentoPanduan Implementasi Kode-kode Emergensicaricato daAura Rachmawati
- DocumentoPANDUAN_IMPLEMENTASI_KODE-KODE_EMERGENSI.docxcaricato daAura Rachmawati
- Documento297570846-FORMULIR-DPJPcaricato daAura Rachmawati
- Documento297570846-FORMULIR-DPJP.docxcaricato daAura Rachmawati
- DocumentoDM TPE 2 USIA LANJUT.pdfcaricato daAura Rachmawati
- DocumentoDM pada usia lanjut.pdfcaricato daAura Rachmawati
- Documentoinfodatin-diabetes.pdfcaricato daAura Rachmawati
- DocumentoLeaflet Supri 1caricato daAura Rachmawati
- DocumentoCairan Dan Elektrolit Des 09caricato daAura Rachmawati
- DocumentoSubclinical Hypothyroid in Children and Adolescentscaricato daAura Rachmawati
- Documentodetection of thyroid dysfunction in early pregnancy.pdfcaricato daAura Rachmawati
- Documentojcem-44-3-481--caricato daAura Rachmawati
- DocumentoSchneider_et_al-2013-CA-_A_Cancer_Journal_for_Clinicians.pdfcaricato daAura Rachmawati
- Documentodokumen.tips_laporan-kasus-hernia-55844c715fead.docxcaricato daAura Rachmawati
- Documentonejmoa1310214[1]caricato daAura Rachmawati
- DocumentoARIA_PG_08_View_WM[1].pdfcaricato daAura Rachmawati
- Documento02-Pelayanan_Imunisasi[1].pdfcaricato daAura Rachmawati
- DocumentoSchneider_et_al-2013-CA-_A_Cancer_Journal_for_Clinicians.pdfcaricato daAura Rachmawati
- DocumentoTargeting the RET Pathway in Thyroid Cancercaricato daAura Rachmawati
- DocumentoPhase II Trial of Sorafenib in Advanced Thyroid Cancercaricato daAura Rachmawati
- DocumentoChemotherapy for Colorectalncancercaricato daAura Rachmawati
- DocumentoPrevalence and Risk Factors of Subclinical Thyroid Diseasecaricato daAura Rachmawati
- DocumentoPrevalence and Risk Factors of Subclinical Thyroid Diseasecaricato daAura Rachmawati
- DocumentoThyroid Cancer Emerging Role for Targeted Therapiescaricato daAura Rachmawati
- DocumentoProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancercaricato daAura Rachmawati
- DocumentoNew Treatment Modalities in Advanced Thyroid Cancercaricato daAura Rachmawati
- DocumentoNew Targeted Therapies for Thyroid Cancercaricato daAura Rachmawati
- DocumentoProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancercaricato daAura Rachmawati
- DocumentoNew Targeted Therapies for Thyroid Cancercaricato daAura Rachmawati
- DocumentoAJHO Apr15 10 Thyroidcaricato daAura Rachmawati
- DocumentoPinestreet.pptxcaricato daAura Rachmawati
- DocumentoDiabetes Control in Thyroid Diseasecaricato daAura Rachmawati
- DocumentoThyroid Size and Goiter Prevalence After Introduction of Iodized Saltcaricato daAura Rachmawati
- DocumentoDetection of Thyroid Dysfunction in Early Pregnancycaricato daAura Rachmawati
- DocumentoProgress in Molecular Targeted Therapy for Thyroid Cancer Vandetanib in Medullary Thyroid Cancercaricato daAura Rachmawati
- DocumentoDetection of Thyroid Dysfunction in Early Pregnancycaricato daAura Rachmawati
- DocumentoAirAsia Prospectus Local English 20101029caricato daAura Rachmawati
- DocumentoCitibank Finalcaricato daAura Rachmawati
- DocumentoAsahi Glasscaricato daAura Rachmawati
- DocumentoAsahi Glasscaricato daAura Rachmawati
- DocumentoNokiacaricato daAura Rachmawati
- Documento1. Cover okcaricato daAura Rachmawati
- DocumentoData Imunisasi Di Puskesmas Tegal Anguscaricato daAura Rachmawati